Objective To evaluate the safety and durability of telitacicept treatment in patients with SLE by identifying the reasons for treatment discontinuation and potential risk factors for subsequent ...

Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus erythematosus (CLE)Litifilimab was recently granted Breakthrough Therapy Desi ...

Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus erythematosus (CLE) Litifilimab was recently granted Bre ...

Objectives To define a clinically meaningful treatment response definition for haemolytic anaemia, that will form part of a novel multidomain outcome measure for SLE clinical trials.Methods An ...

A 19-year-old Chinese woman with a history of systemic lupus erythematous (SLE) visits a rheumatology clinic. She is 24-weeks pregnant and reports ...

The transition from winter to spring in Montana brings dramatic environmental shifts that contribute to the onset of specific dermatologic conditions. Fluctuations in temperature and humidity, alongsi ...

At the 2026 Oscars, comedian Conan O’Brien made a joke during a skit to open the show that negatively associated his appearance with make-up to having lupus. Using lupus as a punchline, especially ...

Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.

The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.

Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential ...

Lupus is more common in Black people, and symptoms can be different too. Here's what to look out for and how to treat it.

Lupus is a disease that primarily affects women – and part of its challenge – besides the complicated symptoms – is its complex diagnosis. Here is everything you need to know.